JP2023036007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023036007A5 JP2023036007A5 JP2022136673A JP2022136673A JP2023036007A5 JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5 JP 2022136673 A JP2022136673 A JP 2022136673A JP 2022136673 A JP2022136673 A JP 2022136673A JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- group
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024074339A JP2024112817A (ja) | 2021-08-31 | 2024-05-01 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021141253 | 2021-08-31 | ||
| JP2021141253 | 2021-08-31 | ||
| JP2022068967 | 2022-04-19 | ||
| JP2022068967 | 2022-04-19 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074339A Division JP2024112817A (ja) | 2021-08-31 | 2024-05-01 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023036007A JP2023036007A (ja) | 2023-03-13 |
| JP2023036007A5 true JP2023036007A5 (enExample) | 2024-01-11 |
| JP7483810B2 JP7483810B2 (ja) | 2024-05-15 |
Family
ID=85411220
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022136673A Active JP7483810B2 (ja) | 2021-08-31 | 2022-08-30 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
| JP2024074339A Pending JP2024112817A (ja) | 2021-08-31 | 2024-05-01 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074339A Pending JP2024112817A (ja) | 2021-08-31 | 2024-05-01 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240287079A1 (enExample) |
| EP (1) | EP4397663A4 (enExample) |
| JP (2) | JP7483810B2 (enExample) |
| KR (1) | KR20240055035A (enExample) |
| AR (1) | AR126912A1 (enExample) |
| AU (1) | AU2022340126A1 (enExample) |
| CA (1) | CA3229401A1 (enExample) |
| CL (1) | CL2024000581A1 (enExample) |
| CO (1) | CO2024002515A2 (enExample) |
| IL (1) | IL310062A (enExample) |
| MX (1) | MX2024002609A (enExample) |
| PE (1) | PE20240882A1 (enExample) |
| TW (1) | TW202328134A (enExample) |
| WO (1) | WO2023032987A1 (enExample) |
| ZA (1) | ZA202400656B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7585409B2 (ja) * | 2022-08-29 | 2024-11-18 | 日本たばこ産業株式会社 | ピラゾロピリミジン化合物及びその医薬用途 |
| AR131919A1 (es) * | 2023-02-24 | 2025-05-14 | Japan Tobacco Inc | Compuestos sustituidos de pirazolopirimidina y su uso médico |
| CN120731207A (zh) * | 2023-02-24 | 2025-09-30 | 日本烟草产业株式会社 | 6-烷氧基吡唑并嘧啶化合物及其药学用途 |
| CN121127471A (zh) | 2023-04-14 | 2025-12-12 | 武田药品工业株式会社 | 作为nlrp3抑制剂的吡唑并嘧啶衍生物 |
| WO2024249539A1 (en) | 2023-06-02 | 2024-12-05 | Merck Sharp & Dohme Llc | 5,6 unsaturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3 |
| WO2025128781A1 (en) * | 2023-12-14 | 2025-06-19 | Merck Sharp & Dohme Llc | Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3 |
| TW202535370A (zh) * | 2023-12-14 | 2025-09-16 | 美商默沙東有限責任公司 | 作為nod樣受體蛋白3抑制劑之吲唑衍生物 |
| CN120230110A (zh) * | 2023-12-31 | 2025-07-01 | 杭州百新生物医药科技有限公司 | 吡唑并嘧啶类化合物及其医药用途 |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012143144A1 (en) * | 2011-04-21 | 2012-10-26 | Origenis Gmbh | Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors |
| WO2017205766A1 (en) * | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
| EP3911417B1 (en) * | 2019-01-14 | 2022-10-26 | Innate Tumor Immunity, Inc. | Heterocyclic nlrp3 modulators , for use in the treatment of cancer |
| JP7335341B2 (ja) * | 2019-01-14 | 2023-08-29 | イネイト・テューマー・イミュニティ・インコーポレイテッド | Ｎｌｒｐ３モジュレーター |
-
2022
- 2022-08-30 WO PCT/JP2022/032606 patent/WO2023032987A1/ja not_active Ceased
- 2022-08-30 PE PE2024000332A patent/PE20240882A1/es unknown
- 2022-08-30 AR ARP220102331A patent/AR126912A1/es unknown
- 2022-08-30 US US18/566,623 patent/US20240287079A1/en active Pending
- 2022-08-30 KR KR1020247010356A patent/KR20240055035A/ko active Pending
- 2022-08-30 AU AU2022340126A patent/AU2022340126A1/en active Pending
- 2022-08-30 JP JP2022136673A patent/JP7483810B2/ja active Active
- 2022-08-30 TW TW111132739A patent/TW202328134A/zh unknown
- 2022-08-30 IL IL310062A patent/IL310062A/en unknown
- 2022-08-30 CA CA3229401A patent/CA3229401A1/en active Pending
- 2022-08-30 EP EP22864569.3A patent/EP4397663A4/en active Pending
- 2022-08-30 MX MX2024002609A patent/MX2024002609A/es unknown
-
2024
- 2024-01-18 ZA ZA2024/00656A patent/ZA202400656B/en unknown
- 2024-02-26 CL CL2024000581A patent/CL2024000581A1/es unknown
- 2024-02-28 CO CONC2024/0002515A patent/CO2024002515A2/es unknown
- 2024-05-01 JP JP2024074339A patent/JP2024112817A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023036007A5 (enExample) | ||
| JP2024032686A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| RU2472509C2 (ru) | Способ лечения артрита | |
| JP2021063088A5 (enExample) | ||
| JP2024120882A5 (enExample) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2014506907A5 (enExample) | ||
| RU2005127356A (ru) | Новая кристаллическая форма триазоло (4,5-d) пиримидина | |
| JPWO2024177126A5 (enExample) | ||
| JP2012521994A5 (enExample) | ||
| JP2005505506A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2014507455A5 (enExample) | ||
| RS53467B (sr) | Upotreba amisulprida za tretiranje mučnine i povraćanja izazvanih hemoterapijom | |
| JP2005502621A5 (enExample) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2018534288A5 (enExample) | ||
| JP2019518779A5 (enExample) | ||
| JP2010505865A5 (enExample) | ||
| JP2020511536A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| JP2003519228A5 (enExample) | ||
| JP2020531463A5 (enExample) |